SecBot SecBot
SECBOTREPLAY Home › Report › KYMR

KYMR · Three Form 144 filings from Kymera Therapeutics on June 17, 2026,…

Kymera Therapeutics, Inc. · 144 filed Jun 17, 2026 at 17:25 ET

At the news

BEARISHIMPACT 4/10

144 filed Jun 17, 2026 at 17:25 ET

Three Form 144 filings from Kymera Therapeutics on June 17, 2026, signal intent to sell by director Bruce Booth (11,741 shares, ~$1.03M) and two Atlas Venture entities (Atlas Venture Fund X: 92,169 shares, ~$8.06M; Atlas Venture Opportunity Fund I: 12,902 shares, ~$1.13M). Combined proposed sales total ~116,812 shares worth ~$10.2M, representing ~0.14% of shares outstanding. While the dollar amount is modest relative to the $7.2B market cap, the coordinated filing by a director and major venture backers on the same day is a mildly negative signal.

  • Bruce Booth (Director) filed to sell 11,741 shares valued at ~$1,026,633.
  • Atlas Venture Fund X, L.P. filed to sell 92,169 shares valued at ~$8,059,257.
  • Atlas Venture Opportunity Fund I, L.P. filed to sell 12,902 shares valued at ~$1,128,151.
  • Total proposed sales: 116,812 shares worth ~$10,214,041.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access